Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Nephrons01:10

Nephrons

2.3K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Core Outcome Set for Localized Renal Cell Cancer (L-RCC-COS).

European urology focus·2026
Same author

State of the nation: Understanding the current NHS treatment pathway to identify opportunities to advance future care of patients with high-risk non-muscle invasive bladder cancer in the UK (SPAN-UK).

BJUI compass·2026
Same author

Characteristics of Patients With Advanced or Metastatic Urothelial Cancer Unable to Complete Six Cycles Chemotherapy.

Cancer medicine·2026
Same author

Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141].

European urology open science·2026
Same author

Modern management of locally advanced renal cancers with inferior vena cava thrombus.

World journal of urology·2026
Same author

Think Twice Before You Continue Long-term FU in Localised nccRCC after Surgery.

European urology oncology·2026

相关实验视频

Updated: Jun 20, 2025

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

16.6K

细胞癌

Matthew Young1, Francesca Jackson-Spence1, Luis Beltran2

  • 1Barts Cancer Institute, Queen Mary University of London, London, UK.

Lancet (London, England)
|July 21, 2024
PubMed
概括
此摘要是机器生成的。

最近的细胞癌治疗进展改善了局部和晚期癌的存活率. 新的辅助疗法如勃利祖马布和免疫检查点抑制剂正在改变治疗模式.

更多相关视频

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

13.6K
Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
05:36

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

8.9K

相关实验视频

Last Updated: Jun 20, 2025

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

16.6K
A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

13.6K
Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
05:36

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

8.9K

科学领域:

  • 癌症学
  • 泌尿外科

背景情况:

  • 治疗细胞癌 (RCC) 的进展显著,改善了患者的存活率.
  • 在治疗局部和晚期癌方面,

研究的目的:

  • 审查RCC的流行病学,病理学和诊断.
  • 讨论当前基于证据的局部转移性RCC的管理策略.
  • 突出未来的研究方向和对癌生物标志物的需求.

主要方法:

  • 对流行病学数据的审查.
  • 对病理发现的分析.
  • 目前和新兴治疗策略的证据综合.
  • 对临床试验的讨论.

主要成果:

  • 辅助疗法,包括pembrolizumab,显示出生存的好处.
  • 免疫检查点抑制剂现在是高级RCC的标准治疗方法.
  • 风险评估模型有助于对转移性RCC进行分层治疗选择.

结论:

  • 目前对细胞癌的治疗策略已经改善了生存结果.
  • 布利祖马布代表了对RCC的辅助治疗的突破.
  • 持续的研究和生物标志物开发对于个性化癌治疗至关重要.